Larvol Delta - Realworld-outcomes-of-ribociclib-treatment-in-HRpositiveHER2negative-metastatic-breast-cancer-efficacy-safety-and-prognostic-factors

Kisqali (ribociclib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42733172

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next